We are not here to advocate for the arms industry or its CEOs, writes STEVE HANDFORD, and that means we must take a stand against the government’s spending on war
Latest editorial
Potential for HIV cure beyond the state of the ART?
Medicine has long been able to guarantee HIV patients an almost normal life and now it can fully cure the virus too — but the treatment is not appropriate for all, explain ROX MIDDLETON, LIAM SHAW and JOEL HELLEWELL
COMPLEX: Watercolour and ink on paper illustration of HIV maturation. After full assembled virus particles have been released from an infected target cell (usually CD4 T cells, a type of white blood cell found in the immune system), they undergo a process
As Labour mimics Tory welfare cuts while ignoring crumbling schools, educators must collectively resist the government's priorities and fight for an inclusive, creative system that values all children, writes NEU president SARAH KILPATRICK
Although our sector is hearing better things from the current government, the recognition that what we do is education in its own right, rather than just childcare, is still not reflected in policy, writes LUCY COLEMAN
Once able to defy a US president before Congress, Netanyahu now finds himself weakened by military setbacks and facing a populist Trump who may yet put ‘America first’ instead of Israel, writes RAMZY BAROUD
RON BROWN makes the case for the Morning Star as the daily paper of all trade unionists, and especially education workers who have seen it cover their issues and their actions, day in, day out
Without due process, hundreds of Venezuelans living in the US have been arrested, slandered as terroristic criminals and sent flown in chains to El Salvador’s notorious mega-prison under an obscure 18th-century law, reports JOHN PERRY
The NEU’s annual conference promises heated debate, with motions on international politics, curriculum reform and union amalgamation likely to provoke strong reactions and challenge the status quo, writes Education for Tomorrow editor ROBERT POOLE
THE development of antiretroviral therapies (ART) has meant that, where available, people living with the human immunodeficiency virus (HIV) now have a normal life expectancy.
Yet despite this achievement, ART is not a cure for HIV and people living with HIV need to keep taking ART for the rest of their life to prevent the development of acquired immune deficiency syndrome (Aids).
As of this moment, two people have been — or at least appear to have been — completely cured of HIV infection, the virus was eradicated from their body and they no longer needed to take ART.
More from this author
A small Japanese trial has reported some positive results for stem cell therapy to treat spinal-cord injuries
Man-made canals like Panama and Suez face unprecedented challenges from extreme weather patterns and geopolitical tensions that reveal the fragility of our global trade networks, write ROX MIDDLETON, LIAM SHAW and MIRIAM GAUNTLETT
It’s sunny times for the solar industry which is expected to continue to grow rapidly — but there are still major environmental issues with how solar cells are made, explain ROX MIDDLETON, LIAM SHAW and MIRIAM GAUNTLETT
Fraud in Alzheimer’s research raises difficult questions about the current state of science, write ROX MIDDLETON, LIAM SHAW and MIRIAM GAUNTLETT